10/2/2009

Impax Laboratories launched its capsule version of Adderall XR, Shire's drug for attention-deficit/hyperactivity disorder. The move comes six months after Teva Pharmaceutical Industries, the first to gain FDA approval for a generic form of Adderall, rolled out its copy.

Related Summaries